Dr. Youssef Hanna


    After Dr. Hanna graduated from the Damascus University School of Medicine in Syria, he completed his internship and residency at Providence Hospital in Southfield, Michigan.  Later, he trained in Medical Oncology as a fellow at Beaumont Hospital in Royal Oak, Michigan, and received board certification in internal medicine and medical oncology. 

    He was practicing as a Medical Oncologist at a full consultative level before joining the Huron Medical Clinic in Port Huron, Michigan as a private practitioner.  He also served on many committees and acted as a consultant to hospitals in the area including Port Huron Hospital, Mercy Hospital, and River District Hospital.

   As a valued Principal Investigator, Dr. Hanna’s research in primary breast cancer therapy was published in Volume 8, Number 3, of The Breast Journal.  He has also served as Principal Investigator in several clinical studies.



Date of birth: December 16, 1969

Place of Birth: Damascus, Syria

Citizenship: United States of America

Marital Status: Married (3 daughters)



American Board of Internal Medicine: Certified (1996 – 2015)

American Board of Internal Medicine, Medical Oncology: Certified (2000 – 2015)

Board Certified and Licensed by the State of Michigan



Degree: Doctor of Medicine Damascus University School of Medicine

Graduation: Class of 1992 {Ranking: Excellent}

Internship: Providence Hospital; Southfield, Michigan 1993 – 1994

Residency: Providence Hospital; Southfield, Michigan 1994 – 1996

Fellowship in Medical Oncology: Beaumont Hospital; Royal Oak, Michigan 1998-2000

Examination: American Board of Internal Medicine: August 1996, Score: Decile 10



Two years practicing as a Primary Care Physician 1996 – 1998. Currently a practicing Medical Oncologist at full consultant level since July 2000; full partner at work.



American Medical Association, American Society of Clinical Oncology,

American Society of Hematology, Michigan State Medical Society,

Michigan Society of Hematology Oncology, Saint Clair County Medical Society,                    

Port Huron Hospital IRB Member.



August 2004- Principal Investigator; A phase three randomized controlled study comparing iron sucrose (venofer) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin therapy.

February 12, 2004- Principal Investigator; 20020122: A randomized, open label, multicenter study of primary versus secondary prophylaxis with Neulasta (pegfilgrastin) as an adjunct to chemotherapy in elderly subjects (> 65 years old) with cancer.

June 2003- Principal Investigator; A multicenter, retrospective survey of the incidence of anemia and outcomes of erythropoietin therapy in patients receiving systemic chemotherapy for cancer protocol P01-02-004-020.

March 2003- Sub investigator; Protocol H3e-us-jmfe open label study of Alimta (Pemetrexed) alone or in combination with Cisplatin for patients with malignant mesothelioma.

Excessive toxicity with concurrent adjuvant Radiation therapy and Paclitaxel in breast cancer patients'. Presented at the San Antonio breast cancer symposium. BUDR improves the cytoxic effect of Cisplatin; presented at OHEP center May 1995, and at the ACP meeting September 1995 (Third Award).



Acute and sub acute toxicity associated with concurrent adjuvant radiation therapy and Paclitaxel in primary breast cancer therapy:  The Breast Journal, Volume 8, Number 3, 2002 149-153 First Author.



McLaren Port Huron Hospital                                  

1221 Pine Grove Avenue                               

P.O. Box 5011

Port Huron, MI 48061-5011

Phone:  810-987-5000

Staff Category:  Active (OCT 1998-current)


Mercy Hospital/Port Huron           

2601 Electric Avenue                                    

Port Huron, MI 48060-6518                        

Phone:  810-985-1500

Staff Category:  Active (JAN 1999-current)


River District Hospital                

St John Health System                                  

4100 River Road

East China, MI 48054-2914

Phone:  810-329-7111

Staff Category: Consultant (Jan. 1999-current)